How We Formulate
The thinking behind
every OGINÉA formula.
A product begins long before its ingredients appear on a label. Here is the process we follow to get there.
At OGINÉA, we develop each formula through a series of questions. Why should this product exist? What does the evidence support? Which ingredients belong in it? In what amount and form? How will the finished product work in everyday life? And are we prepared to stand behind the way we describe it?
Our development process draws on expertise in pharmaceutical formulation and pharmacy, with additional input from manufacturers, laboratories, regulatory advisers and other qualified specialists when needed.
Different products require different decisions. The discipline behind those decisions remains the same.
Six questions behind every formula
How each step actually works
Define the purpose
Every product starts with a reason.
Before selecting ingredients, we define what the product is intended to support, who it is being designed for and how it is expected to fit into everyday use.
This gives the formula a clear boundary.
We do not begin by asking how many ingredients we can include. We begin by asking what the product actually needs.
A clear purpose makes it easier to decide what belongs in the formula and, just as importantly, what does not.
Review the evidence
Once the purpose is clear, we look at the research that may inform the formulation.
We consider the ingredient and form studied, the amount used, the population, the duration and the outcomes that were measured.
We also look at the limits of the evidence.
Research on an individual ingredient can help guide a formulation decision, but it does not automatically mean that a finished product has been clinically proven.
When the evidence relates to an ingredient rather than the complete formula, we keep that distinction clear.
Build the formula
The next step is deciding which ingredients belong in the product and how they should be used.
We consider the amount, the form, the source and any specifications that are important to understanding the ingredient.
These details can make a meaningful difference.
A mineral may be available in several forms. A botanical extract may be standardised to particular compounds. Other ingredients may require different specifications depending on their source or processing.
We also look at how the ingredients work together.
A longer ingredient list does not necessarily make a better formula. We want to be able to explain why each ingredient is there and why the chosen amount and form make sense.
Develop the finished product
A formula still has to become a product someone can realistically use.
The questions at this stage depend on the format.
For a drink, taste, solubility and preparation may matter. For a capsule, serving size and capsule count may become important. Other formats bring different practical considerations.
Stability, convenience and the experience of regular use can also affect development.
We consider these factors because the way a product is used is part of the product itself.
Scientific logic and everyday experience should make sense together.
Review quality and manufacturing
Once a formula moves towards production, we review the requirements that are relevant to making it consistently and appropriately.
This may include ingredient specifications, manufacturing requirements, supplier documentation, certificates, analytical information and other quality checks appropriate to the product.
The exact requirements are not identical for every OGINÉA formula.
A mineral supplement, a botanical infusion and a functional drink may require different controls.
What matters is that the relevant quality requirements are defined, documented and reviewed before the product reaches the customer.
Where additional specialist expertise is needed, we work with appropriate manufacturers, laboratories, regulatory advisers and other qualified partners.
Review what we say
The final review is not limited to what goes into the product.
It also includes what we are prepared to say about it.
A scientific reference does not justify every possible claim. We consider whether the language used reflects the evidence, whether the evidence relates to an individual ingredient or the finished formula, and whether the statement is appropriate for the market in which the product will be sold.
Sometimes the accurate version is less dramatic than the marketing alternative. We are comfortable with that.
If a finished OGINÉA formula has not itself been clinically studied, we do not want research on its individual ingredients to create the impression that it has.
Scientific review should help us communicate more accurately, not simply more confidently.
No single template
There is no single formulation template for every OGINÉA product. The questions that matter for a mineral supplement may differ from those that matter for a botanical infusion or a functional food. What should remain consistent is the level of attention given to the decisions behind the product.
Visible in the decisions, not the title
OGINÉA product development is supported by expertise in pharmaceutical formulation and pharmacy. We do not ask customers to trust a formula simply because someone with a particular qualification was involved. The value of expertise should be visible in the work itself, and when a product requires knowledge outside our internal scope, we seek appropriate specialist input.
From formulation to The OGINÉA Standard
Clarity is part of the product.
Our formulation process describes how many of the decisions behind a product are made. The OGINÉA Standard gives customers a way to understand and examine those decisions: whether the purpose is clear, whether the formula can be explained, whether the evidence has been read in context, whether the relevant quality requirements have been considered and whether the product makes sense in real life.
Clarity should be part of the product itself, not something added later in the marketing.